サマリー

市場分析とインサイト全身性アスペルギルス症と全身性カンジダ症の世界市場
COVID-19の流行により、全身性アスペルギルス症および全身性カンジダ症の世界市場規模は、2022年には100万米ドルと推定され、2028年には再調整後の市場規模が100万米ドルになると予測されています（検討期間中のCAGRは%です）。この健康危機による経済的変化を十分に考慮した上で、ボリコナゾールは、2021年には全身性アスペルギルス症および全身性カンジダ症の世界市場の％を占めていましたが、COVID-19後の期間には改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、CPAセグメントは、この予測期間中、% CAGRで変化しています。
中国の全身性アスペルギルス症および全身性カンジダ症の市場規模は2021年に百万米ドル、米国および欧州の全身性アスペルギルス症および全身性カンジダ症はそれぞれ百万米ドル、百万米ドルとなっています。米国の割合は2021年には％、中国と欧州はそれぞれ％と％で、中国の割合は2028年には％に達し、分析期間中のCAGRは％になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の全身性アスペルギルス症および全身性カンジダ症市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中の年平均成長率は%となっています。
全身性アスペルギルス症および全身性カンジダ症の世界的な主要メーカーには、ノバルティスAG、ファイザー、サノフィ・アベンティス、メルク・アンド・カンパニー、エンゾン・ファーマシューティカルズ、バイエルAG、アステラス製薬、グラクソ・スミスクライン・ピーエルシー、アボットなどがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
世界の全身性アスペルギルス症および全身性カンジダ症の範囲とセグメント
全身性アスペルギルス症および全身性カンジダ症の市場は、タイプ別およびアプリケーション別に分類されます。世界のSystemic Aspergillosis and Systemic Candidasis市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
ボリコナゾール
リポソーム型アンフォテリシンB
全身用経口アゾール系抗真菌剤
外用抗真菌剤
その他
用途別セグメント
CPA
ABPA
消化器系カンジダ症
泌尿生殖器系カンジダ症
その他
会社別
ノバルティス社
Pfizer, Inc.
サノフィ・アベンティス
メルク・アンド・カンパニー
エンゾン・ファーマシューティカルズ・インク
バイエル株式会社
アステラス製薬株式会社
グラクソ・スミスクライン・ピーエルシー
アボット
地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Systemic Aspergillosis and Systemic Candidasis Product Introduction
1.2 Market by Type
1.2.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Voriconazole
1.2.3 Liposomal Amphotericin B
1.2.4 Systemic Oral Azoles
1.2.5 Topical Antifungal Agents
1.2.6 Other
1.3 Market by Application
1.3.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 CPA
1.3.3 ABPA
1.3.4 Gastrointestinal Candidiasis
1.3.5 Genitourinary Tract Candidiasis
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Systemic Aspergillosis and Systemic Candidasis Sales Estimates and Forecasts 2017-2028
2.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue Estimates and Forecasts 2017-2028
2.3 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Systemic Aspergillosis and Systemic Candidasis Sales by Region
2.4.1 Global Systemic Aspergillosis and Systemic Candidasis Sales by Region (2017-2022)
2.4.2 Global Sales Systemic Aspergillosis and Systemic Candidasis by Region (2023-2028)
2.5 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region
2.5.1 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2022)
2.5.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Systemic Aspergillosis and Systemic Candidasis Sales by Manufacturers
3.1.1 Global Top Systemic Aspergillosis and Systemic Candidasis Manufacturers by Sales (2017-2022)
3.1.2 Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Systemic Aspergillosis and Systemic Candidasis in 2021
3.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturers
3.2.1 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturers (2017-2022)
3.2.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Systemic Aspergillosis and Systemic Candidasis Revenue in 2021
3.3 Global Systemic Aspergillosis and Systemic Candidasis Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Systemic Aspergillosis and Systemic Candidasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Systemic Aspergillosis and Systemic Candidasis Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Systemic Aspergillosis and Systemic Candidasis Sales by Type
4.1.1 Global Systemic Aspergillosis and Systemic Candidasis Historical Sales by Type (2017-2022)
4.1.2 Global Systemic Aspergillosis and Systemic Candidasis Forecasted Sales by Type (2023-2028)
4.1.3 Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2017-2028)
4.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type
4.2.1 Global Systemic Aspergillosis and Systemic Candidasis Historical Revenue by Type (2017-2022)
4.2.2 Global Systemic Aspergillosis and Systemic Candidasis Forecasted Revenue by Type (2023-2028)
4.2.3 Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Type (2017-2028)
4.3 Global Systemic Aspergillosis and Systemic Candidasis Price by Type
4.3.1 Global Systemic Aspergillosis and Systemic Candidasis Price by Type (2017-2022)
4.3.2 Global Systemic Aspergillosis and Systemic Candidasis Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Systemic Aspergillosis and Systemic Candidasis Sales by Application
5.1.1 Global Systemic Aspergillosis and Systemic Candidasis Historical Sales by Application (2017-2022)
5.1.2 Global Systemic Aspergillosis and Systemic Candidasis Forecasted Sales by Application (2023-2028)
5.1.3 Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2017-2028)
5.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application
5.2.1 Global Systemic Aspergillosis and Systemic Candidasis Historical Revenue by Application (2017-2022)
5.2.2 Global Systemic Aspergillosis and Systemic Candidasis Forecasted Revenue by Application (2023-2028)
5.2.3 Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Application (2017-2028)
5.3 Global Systemic Aspergillosis and Systemic Candidasis Price by Application
5.3.1 Global Systemic Aspergillosis and Systemic Candidasis Price by Application (2017-2022)
5.3.2 Global Systemic Aspergillosis and Systemic Candidasis Price Forecast by Application (2023-2028)
6 North America
6.1 North America Systemic Aspergillosis and Systemic Candidasis Market Size by Type
6.1.1 North America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
6.1.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2028)
6.2 North America Systemic Aspergillosis and Systemic Candidasis Market Size by Application
6.2.1 North America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
6.2.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2028)
6.3 North America Systemic Aspergillosis and Systemic Candidasis Market Size by Country
6.3.1 North America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2017-2028)
6.3.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Systemic Aspergillosis and Systemic Candidasis Market Size by Type
7.1.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
7.1.2 Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2028)
7.2 Europe Systemic Aspergillosis and Systemic Candidasis Market Size by Application
7.2.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
7.2.2 Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2028)
7.3 Europe Systemic Aspergillosis and Systemic Candidasis Market Size by Country
7.3.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Country (2017-2028)
7.3.2 Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Size by Type
8.1.1 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
8.1.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2028)
8.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Size by Application
8.2.1 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
8.2.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2028)
8.3 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Market Size by Region
8.3.1 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Region (2017-2028)
8.3.2 Asia Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Systemic Aspergillosis and Systemic Candidasis Market Size by Type
9.1.1 Latin America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
9.1.2 Latin America Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2028)
9.2 Latin America Systemic Aspergillosis and Systemic Candidasis Market Size by Application
9.2.1 Latin America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
9.2.2 Latin America Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2028)
9.3 Latin America Systemic Aspergillosis and Systemic Candidasis Market Size by Country
9.3.1 Latin America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2017-2028)
9.3.2 Latin America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Market Size by Type
10.1.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
10.1.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2028)
10.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Market Size by Application
10.2.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
10.2.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2028)
10.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Market Size by Country
10.3.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Sales by Country (2017-2028)
10.3.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Overview
11.1.3 Novartis AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis AG Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis AG Recent Developments
11.2 Pfizer, Inc
11.2.1 Pfizer, Inc Corporation Information
11.2.2 Pfizer, Inc Overview
11.2.3 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer, Inc Recent Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Overview
11.3.3 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Aventis Recent Developments
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Corporation Information
11.4.2 Merck & Co., Inc Overview
11.4.3 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co., Inc Recent Developments
11.5 Enzon Pharmaceuticals, Inc
11.5.1 Enzon Pharmaceuticals, Inc Corporation Information
11.5.2 Enzon Pharmaceuticals, Inc Overview
11.5.3 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Enzon Pharmaceuticals, Inc Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Corporation Information
11.6.2 Bayer AG Overview
11.6.3 Bayer AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer AG Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer AG Recent Developments
11.7 Astellas Pharma, Inc
11.7.1 Astellas Pharma, Inc Corporation Information
11.7.2 Astellas Pharma, Inc Overview
11.7.3 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astellas Pharma, Inc Recent Developments
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Corporation Information
11.8.2 GlaxoSmithKline plc Overview
11.8.3 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline plc Recent Developments
11.9 Abbott
11.9.1 Abbott Corporation Information
11.9.2 Abbott Overview
11.9.3 Abbott Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Abbott Systemic Aspergillosis and Systemic Candidasis Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbott Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Systemic Aspergillosis and Systemic Candidasis Industry Chain Analysis
12.2 Systemic Aspergillosis and Systemic Candidasis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Systemic Aspergillosis and Systemic Candidasis Production Mode & Process
12.4 Systemic Aspergillosis and Systemic Candidasis Sales and Marketing
12.4.1 Systemic Aspergillosis and Systemic Candidasis Sales Channels
12.4.2 Systemic Aspergillosis and Systemic Candidasis Distributors
12.5 Systemic Aspergillosis and Systemic Candidasis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Systemic Aspergillosis and Systemic Candidasis Industry Trends
13.2 Systemic Aspergillosis and Systemic Candidasis Market Drivers
13.3 Systemic Aspergillosis and Systemic Candidasis Market Challenges
13.4 Systemic Aspergillosis and Systemic Candidasis Market Restraints
14 Key Findings in The Global Systemic Aspergillosis and Systemic Candidasis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer